Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.20% | 35.64 | 0.8% | $766.84m | |
| JNJ | Johnson & Johnson | 0.34% | 124.27 | 0.6% | $764.41m | |
| ABBV | AbbVie, Inc. | 0.60% | 105.95 | 2.1% | $720.72m | |
| MRK | Merck & Co., Inc. | 0.10% | 59.13 | 0.6% | $610.36m | |
| BMY | Bristol-Myers Squibb Company | -0.08% | 52.70 | 1.4% | $505.02m | |
| LLY | Eli Lilly and Company | 0.48% | 82.05 | 1.0% | $360.75m | |
| AZN | AstraZeneca PLC Sponsored ADR | -0.30% | 36.33 | 1.3% | $153.42m | |
| NVS | Novartis AG Sponsored ADR | -0.10% | 77.07 | 0.2% | $134.97m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | -0.15% | 40.04 | 0.2% | $111.26m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -0.55% | 48.72 | 0.1% | $80.36m | |
| SNY | Sanofi Sponsored ADR | -0.05% | 38.87 | 0.2% | $45.16m | |
| LCI | Lannett Company, Inc. | -0.15% | 16.18 | 37.9% | $12.30m | |
| EPIX | ESSA Pharma Inc | 1.14% | 3.56 | 0.0% | $0.20m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -1.05% | 1.88 | 1.7% | $0.11m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.